DAFNA CAPITAL MANAGEMENT LLC Holdings

DAFNA CAPITAL MANAGEMENT LLC is an investment fund managing more than 371.81M US dollars. The largest holdings include SPDR S&P Biotech ETF, Stereotaxis and Blueprint Medicines. In Q3 2022 the fund bought assets of total value of 18.94M US dollars and sold assets of total value of 2.86M US dollars.

$371.80M

portfolio value

+9.33%

quarter

-39.67%

1 year

+6.94%

3 years

+56.42%

5 years

DAFNA CAPITAL MANAGEMENT LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	19026000	11155000
Q2 2016	22294000	9336000
Q3 2016	36086000	21257000
Q4 2016	12833000	12599000
Q1 2017	23654000	16366000
Q2 2017	25442000	4788000
Q3 2017	19641000	2356000
Q4 2017	33005000	7759000
Q1 2018	44288000	22600000
Q2 2018	12265000	6800000
Q3 2018	23506000	469000
Q4 2018	-6970000	12927000
Q1 2019	44505000	4870000
Q2 2019	36244000	11874000
Q3 2019	14249000	13521000
Q4 2019	20485000	13190000
Q1 2020	16782000	16943000
Q2 2020	70830000	519000
Q3 2020	37841000	51728000
Q4 2020	38563000	9718000
Q1 2021	82895000	20068000
Q2 2021	47142000	28201000
Q3 2021	13674000	28426000
Q4 2021	47379000	13445000
Q1 2022	44508000	5821000
Q2 2022	38120000	12213000
Q3 2022	18944000	2864000

DAFNA CAPITAL MANAGEMENT LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
SPDR S&P Biotech ETF Portfolio share: 12.07% Portfolio value: 44.89M Avg. open price: $89.88 Current price: $82.88 P/L: -7.79% Sold -7.67% shares Q3 2022	share	12.07%	44.89M	$89.88	$82.88	-7.79%	Sold -7.67% shares Q3 2022
Medical Instruments & Supplies Stereotaxis, Inc. Portfolio share: 6.62% Portfolio value: 24.62M Avg. open price: $0.8 Current price: $2.23 P/L: +178.75% Bought +896.50% shares Q1 2018	share	6.62%	24.62M	$0.8	$2.23	+178.75%	Bought +896.50% shares Q1 2018
Biotechnology Blueprint Medicines Corporation Portfolio share: 4.63% Portfolio value: 17.21M Avg. open price: $77.95 Current price: $50.19 P/L: -35.61% Sold -0.02% shares Q3 2022	share	4.63%	17.21M	$77.95	$50.19	-35.61%	Sold -0.02% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 4.48% Portfolio value: 16.64M Avg. open price: $74.91 Current price: $16.32 P/L: -78.21% Bought +41.88% shares Q2 2022	share	4.48%	16.64M	$74.91	$16.32	-78.21%	Bought +41.88% shares Q2 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 3.77% Portfolio value: 14.01M Avg. open price: $82.12 Current price: $119.41 P/L: +45.42% Sold -2.51% shares Q3 2022	share	3.77%	14.01M	$82.12	$119.41	+45.42%	Sold -2.51% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 3.64% Portfolio value: 13.54M Avg. open price: $9.71 Current price: $38.83 P/L: +299.95% Sold -14.45% shares Q3 2022	share	3.64%	13.54M	$9.71	$38.83	+299.95%	Sold -14.45% shares Q3 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 3.58% Portfolio value: 13.30M Avg. open price: $13 Current price: $20.2 P/L: +55.35% Bought +30.72% shares Q2 2022	share	3.58%	13.30M	$13	$20.2	+55.35%	Bought +30.72% shares Q2 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 3.25% Portfolio value: 12.1M Avg. open price: $34.03 Current price: $20.4 P/L: -40.05% Sold -2.00% shares Q3 2022	share	3.25%	12.1M	$34.03	$20.4	-40.05%	Sold -2.00% shares Q3 2022
iShares Biotechnology ETF Portfolio share: 3.22% Portfolio value: 11.98M Avg. open price: $138.67 Current price: $135.49 P/L: -2.30% Bought +150.61% shares Q1 2022	share	3.22%	11.98M	$138.67	$135.49	-2.30%	Bought +150.61% shares Q1 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 2.54% Portfolio value: 9.46M Avg. open price: $29.72 Current price: $24.32 P/L: -18.18% Bought +60.04% shares Q3 2022	share	2.54%	9.46M	$29.72	$24.32	-18.18%	Bought +60.04% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 2.40% Portfolio value: 8.91M Avg. open price: $12.25 Current price: $38.12 P/L: +211.18% Sold -13.00% shares Q3 2022	share	2.40%	8.91M	$12.25	$38.12	+211.18%	Sold -13.00% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 2.30% Portfolio value: 8.54M Avg. open price: $20.61 Current price: $25.44 P/L: +23.44% Sold -4.18% shares Q3 2022	share	2.30%	8.54M	$20.61	$25.44	+23.44%	Sold -4.18% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 2.29% Portfolio value: 8.51M Avg. open price: $107.87 Current price: $124 P/L: +14.95% Sold -3.02% shares Q3 2022	share	2.29%	8.51M	$107.87	$124	+14.95%	Sold -3.02% shares Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 2.16% Portfolio value: 8.03M Avg. open price: $18.7 Current price: $17.77 P/L: -4.96% Sold -1.82% shares Q3 2022	share	2.16%	8.03M	$18.7	$17.77	-4.96%	Sold -1.82% shares Q3 2022
Biotechnology Edgewise Therapeutics, Inc. Portfolio share: 2.07% Portfolio value: 7.68M Avg. open price: $9.35 Current price: $8.83 P/L: -5.57% Bought +12.24% shares Q3 2022	share	2.07%	7.68M	$9.35	$8.83	-5.57%	Bought +12.24% shares Q3 2022
Biotechnology Nurix Therapeutics, Inc. Portfolio share: 1.99% Portfolio value: 7.38M Avg. open price: $28.55 Current price: $12.38 P/L: -56.63% Bought +4.30% shares Q2 2022	share	1.99%	7.38M	$28.55	$12.38	-56.63%	Bought +4.30% shares Q2 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 1.94% Portfolio value: 7.20M Avg. open price: $12.05 Current price: $21.89 P/L: +81.63% Sold -0.25% shares Q3 2022	share	1.94%	7.20M	$12.05	$21.89	+81.63%	Sold -0.25% shares Q3 2022
Biotechnology Sage Therapeutics, Inc. Portfolio share: 1.90% Portfolio value: 7.06M Avg. open price: $113.47 Current price: $43.52 P/L: -61.65% Bought +5.87% shares Q3 2021	share	1.90%	7.06M	$113.47	$43.52	-61.65%	Bought +5.87% shares Q3 2021
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 1.75% Portfolio value: 6.49M Avg. open price: $104.98 Current price: $226.95 P/L: +116.18% Sold -53.45% shares Q3 2022	share	1.75%	6.49M	$104.98	$226.95	+116.18%	Sold -53.45% shares Q3 2022
Biotechnology CymaBay Therapeutics, Inc. Portfolio share: 1.60% Portfolio value: 5.96M Avg. open price: $4.6 Current price: $4.17 P/L: -9.26% Sold -4.72% shares Q3 2022	share	1.60%	5.96M	$4.6	$4.17	-9.26%	Sold -4.72% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 1.57% Portfolio value: 5.84M Avg. open price: $58.44 Current price: $116.56 P/L: +99.44% Sold -14.19% shares Q4 2021	share	1.57%	5.84M	$58.44	$116.56	+99.44%	Sold -14.19% shares Q4 2021
Biotechnology Merus N.V. Portfolio share: 1.49% Portfolio value: 5.54M Avg. open price: $23.55 Current price: $14.2 P/L: -39.70% Bought +5.33% shares Q3 2022	share	1.49%	5.54M	$23.55	$14.2	-39.70%	Bought +5.33% shares Q3 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 1.49% Portfolio value: 5.53M Avg. open price: $34.24 Current price: $26.56 P/L: -22.43% Bought +7.71% shares Q2 2022	share	1.49%	5.53M	$34.24	$26.56	-22.43%	Bought +7.71% shares Q2 2022
Biotechnology Alector, Inc. Portfolio share: 1.35% Portfolio value: 5.03M Avg. open price: $17.61 Current price: $8.68 P/L: -50.70% Sold -3.62% shares Q3 2022	share	1.35%	5.03M	$17.61	$8.68	-50.70%	Sold -3.62% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 1.35% Portfolio value: 5.00M Avg. open price: $82.22 Current price: $92.75 P/L: +12.81% Sold -10.05% shares Q3 2022	share	1.35%	5.00M	$82.22	$92.75	+12.81%	Sold -10.05% shares Q3 2022
Biotechnology Century Therapeutics, Inc. Portfolio share: 1.26% Portfolio value: 4.70M Avg. open price: $14.32 Current price: $10.25 P/L: -28.40% Bought +85.05% shares Q2 2022	share	1.26%	4.70M	$14.32	$10.25	-28.40%	Bought +85.05% shares Q2 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 1.26% Portfolio value: 4.67M Avg. open price: $27.49 Current price: $33.96 P/L: +23.55% Sold -4.79% shares Q3 2022	share	1.26%	4.67M	$27.49	$33.96	+23.55%	Sold -4.79% shares Q3 2022
Drug Manufacturers—Specialty & Generic Aerie Pharmaceuticals, Inc. Portfolio share: 1.25% Portfolio value: 4.64M Avg. open price: $35.53 Current price: $15.25 P/L: -57.08% Bought +6.29% shares Q3 2022	share	1.25%	4.64M	$35.53	$15.25	-57.08%	Bought +6.29% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 1.21% Portfolio value: 4.50M Avg. open price: $33.22 Current price: $49.41 P/L: +48.74% Sold -31.97% shares Q3 2022	share	1.21%	4.50M	$33.22	$49.41	+48.74%	Sold -31.97% shares Q3 2022
Medical Devices Cardiovascular Systems, Inc. Portfolio share: 1.07% Portfolio value: 3.97M Avg. open price: $36.05 Current price: $13.65 P/L: -62.14% Bought +48.13% shares Q4 2021	share	1.07%	3.97M	$36.05	$13.65	-62.14%	Bought +48.13% shares Q4 2021
Medical Devices AxoGen, Inc. Portfolio share: 1.06% Portfolio value: 3.95M Avg. open price: N/A Current price: $10.93 P/L: N/A N/A Q4 2021	share	1.06%	3.95M	N/A	$10.93	N/A	N/A Q4 2021
Biotechnology 89bio, Inc. Portfolio share: 1.02% Portfolio value: 3.79M Avg. open price: $8.92 Current price: $8.34 P/L: -6.51% Sold -14.60% shares Q3 2022	share	1.02%	3.79M	$8.92	$8.34	-6.51%	Sold -14.60% shares Q3 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 1.00% Portfolio value: 3.70M Avg. open price: $19.24 Current price: $5.17 P/L: -73.13% Sold -3.90% shares Q3 2022	share	1.00%	3.70M	$19.24	$5.17	-73.13%	Sold -3.90% shares Q3 2022
Biotechnology F-star Therapeutics, Inc. Portfolio share: 0.79% Portfolio value: 2.95M Avg. open price: N/A Current price: $5.55 P/L: N/A Sold -16.85% shares Q2 2022	share	0.79%	2.95M	N/A	$5.55	N/A	Sold -16.85% shares Q2 2022
Biotechnology Bicycle Therapeutics plc Portfolio share: 0.76% Portfolio value: 2.84M Avg. open price: $43.88 Current price: $32.41 P/L: -26.14% Sold -6.86% shares Q3 2022	share	0.76%	2.84M	$43.88	$32.41	-26.14%	Sold -6.86% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 0.76% Portfolio value: 2.81M Avg. open price: $18.59 Current price: $15.82 P/L: -14.91% Bought +75.11% shares Q3 2022	share	0.76%	2.81M	$18.59	$15.82	-14.91%	Bought +75.11% shares Q3 2022
Medical Instruments & Supplies AtriCure, Inc. Portfolio share: 0.76% Portfolio value: 2.81M Avg. open price: $23.1 Current price: $43.65 P/L: +88.98% Sold -21.30% shares Q3 2021	share	0.76%	2.81M	$23.1	$43.65	+88.98%	Sold -21.30% shares Q3 2021
Biotechnology Mersana Therapeutics, Inc. Portfolio share: 0.69% Portfolio value: 2.55M Avg. open price: $7.29 Current price: $7.05 P/L: -3.32% Sold -7.13% shares Q3 2022	share	0.69%	2.55M	$7.29	$7.05	-3.32%	Sold -7.13% shares Q3 2022
Biotechnology MediWound Ltd. Portfolio share: 0.53% Portfolio value: 1.98M Avg. open price: N/A Current price: $1.44 P/L: N/A N/A Q3 2022	share	0.53%	1.98M	N/A	$1.44	N/A	N/A Q3 2022
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.53% Portfolio value: 1.96M Avg. open price: $2.58 Current price: $12 P/L: +365.12% Bought +116.93% shares Q3 2022	share	0.53%	1.96M	$2.58	$12	+365.12%	Bought +116.93% shares Q3 2022
Medical Devices Accuray Incorporated Portfolio share: 0.53% Portfolio value: 1.95M Avg. open price: $2.53 Current price: $2.02 P/L: -20.22% Sold -3.35% shares Q1 2021	share	0.53%	1.95M	$2.53	$2.02	-20.22%	Sold -3.35% shares Q1 2021
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 0.50% Portfolio value: 1.85M Avg. open price: $42.89 Current price: $20.04 P/L: -53.27% Sold -7.35% shares Q3 2022	share	0.50%	1.85M	$42.89	$20.04	-53.27%	Sold -7.35% shares Q3 2022
Biotechnology Larimar Therapeutics, Inc. Portfolio share: 0.49% Portfolio value: 1.84M Avg. open price: $3.2 Current price: $3.15 P/L: -1.42% Bought +1050.08% shares Q3 2022	share	0.49%	1.84M	$3.2	$3.15	-1.42%	Bought +1050.08% shares Q3 2022
Biotechnology Galapagos NV Portfolio share: 0.49% Portfolio value: 1.82M Avg. open price: $99.99 Current price: $38.92 P/L: -61.08% Sold -45.06% shares Q4 2021	share	0.49%	1.82M	$99.99	$38.92	-61.08%	Sold -45.06% shares Q4 2021
Biotechnology Syros Pharmaceuticals, Inc. Portfolio share: 0.46% Portfolio value: 1.71M Avg. open price: N/A Current price: $3.83 P/L: N/A N/A Q3 2022	share	0.46%	1.71M	N/A	$3.83	N/A	N/A Q3 2022
Biotechnology DICE Therapeutics, Inc. Portfolio share: 0.43% Portfolio value: 1.59M Avg. open price: $19.13 Current price: $34.51 P/L: +80.40% Sold -49.97% shares Q3 2022	share	0.43%	1.59M	$19.13	$34.51	+80.40%	Sold -49.97% shares Q3 2022
Biotechnology Viking Therapeutics, Inc. Portfolio share: 0.40% Portfolio value: 1.50M Avg. open price: $6.74 Current price: $3.97 P/L: -41.06% Bought +19.46% shares Q3 2022	share	0.40%	1.50M	$6.74	$3.97	-41.06%	Bought +19.46% shares Q3 2022
AERIE PHARMACEUTICALS INC Portfolio share: 0.40% Portfolio value: 1.47M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2020	share	0.40%	1.47M	N/A	N/A	N/A	N/A Q3 2020
Biotechnology Keros Therapeutics, Inc. Portfolio share: 0.39% Portfolio value: 1.46M Avg. open price: N/A Current price: $50 P/L: N/A N/A Q2 2022	share	0.39%	1.46M	N/A	$50	N/A	N/A Q2 2022
Biotechnology Affimed N.V. Portfolio share: 0.38% Portfolio value: 1.41M Avg. open price: $4.97 Current price: $2.12 P/L: -57.47% Bought +20.13% shares Q2 2022	share	0.38%	1.41M	$4.97	$2.12	-57.47%	Bought +20.13% shares Q2 2022
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 0.36% Portfolio value: 1.32M Avg. open price: N/A Current price: $4.02 P/L: N/A Sold -0.58% shares Q3 2022	share	0.36%	1.32M	N/A	$4.02	N/A	Sold -0.58% shares Q3 2022
Biotechnology Surface Oncology, Inc. Portfolio share: 0.31% Portfolio value: 1.14M Avg. open price: $3.83 Current price: $0.91 P/L: -76.18% Bought +61.76% shares Q2 2022	share	0.31%	1.14M	$3.83	$0.91	-76.18%	Bought +61.76% shares Q2 2022
Biotechnology Autolus Therapeutics plc Portfolio share: 0.29% Portfolio value: 1.06M Avg. open price: $13.2 Current price: $3.22 P/L: -75.61% N/A Q1 2022	share	0.29%	1.06M	$13.2	$3.22	-75.61%	N/A Q1 2022
Diagnostics & Research Neuronetics, Inc. Portfolio share: 0.27% Portfolio value: 998K Avg. open price: $8.49 Current price: $6.2 P/L: -26.97% Bought +23.65% shares Q3 2021	share	0.27%	998K	$8.49	$6.2	-26.97%	Bought +23.65% shares Q3 2021
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 0.26% Portfolio value: 980K Avg. open price: $21.28 Current price: $5.6 P/L: -73.69% Sold -30.38% shares Q3 2022	share	0.26%	980K	$21.28	$5.6	-73.69%	Sold -30.38% shares Q3 2022
Biotechnology Gamida Cell Ltd. Portfolio share: 0.26% Portfolio value: 978K Avg. open price: N/A Current price: $1.43 P/L: N/A N/A Q3 2022	share	0.26%	978K	N/A	$1.43	N/A	N/A Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 0.26% Portfolio value: 967K Avg. open price: $74.91 Current price: $16.32 P/L: -78.21% N/A Q3 2022	share	0.26%	967K	$74.91	$16.32	-78.21%	N/A Q3 2022
Drug Manufacturers—Specialty & Generic SCYNEXIS, Inc. Portfolio share: 0.26% Portfolio value: 958K Avg. open price: $10.96 Current price: $2.11 P/L: -80.75% Sold -12.20% shares Q3 2022	share	0.26%	958K	$10.96	$2.11	-80.75%	Sold -12.20% shares Q3 2022
Biotechnology Mereo BioPharma Group plc Portfolio share: 0.25% Portfolio value: 944K Avg. open price: $3.03 Current price: $0.83 P/L: -72.55% Sold -9.87% shares Q2 2022	share	0.25%	944K	$3.03	$0.83	-72.55%	Sold -9.87% shares Q2 2022
Biotechnology Regulus Therapeutics Inc. Portfolio share: 0.25% Portfolio value: 944K Avg. open price: $102.7 Current price: $1.74 P/L: -98.31% N/A Q2 2022	share	0.25%	944K	$102.7	$1.74	-98.31%	N/A Q2 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.25% Portfolio value: 933K Avg. open price: $16.76 Current price: $7.05 P/L: -57.93% Sold -65.22% shares Q3 2022	share	0.25%	933K	$16.76	$7.05	-57.93%	Sold -65.22% shares Q3 2022
Biotechnology Pardes Biosciences, Inc. Portfolio share: 0.24% Portfolio value: 887K Avg. open price: $14.22 Current price: $1.1 P/L: -92.27% Bought +6.27% shares Q3 2022	share	0.24%	887K	$14.22	$1.1	-92.27%	Bought +6.27% shares Q3 2022
Medical Devices BrainsWay Ltd. Portfolio share: 0.21% Portfolio value: 794K Avg. open price: $4.83 Current price: $1.86 P/L: -61.49% Bought +10.00% shares Q3 2022	share	0.21%	794K	$4.83	$1.86	-61.49%	Bought +10.00% shares Q3 2022
Biotechnology Genfit S.A. Portfolio share: 0.18% Portfolio value: 686K Avg. open price: $4.89 Current price: $3.67 P/L: -24.93% Bought +210.91% shares Q1 2022	share	0.18%	686K	$4.89	$3.67	-24.93%	Bought +210.91% shares Q1 2022
Biotechnology MEI Pharma, Inc. Portfolio share: 0.18% Portfolio value: 683K Avg. open price: $3.24 Current price: $0.39 P/L: -87.93% Bought +0.13% shares Q1 2022	share	0.18%	683K	$3.24	$0.39	-87.93%	Bought +0.13% shares Q1 2022
Biotechnology GH Research PLC Portfolio share: 0.16% Portfolio value: 612K Avg. open price: N/A Current price: $11.4 P/L: N/A Sold -4.31% shares Q3 2022	share	0.16%	612K	N/A	$11.4	N/A	Sold -4.31% shares Q3 2022
Biotechnology Medicenna Therapeutics Corp. Portfolio share: 0.15% Portfolio value: 548K Avg. open price: N/A Current price: $0.57 P/L: N/A N/A Q3 2022	share	0.15%	548K	N/A	$0.57	N/A	N/A Q3 2022
Biotechnology Black Diamond Therapeutics, Inc. Portfolio share: 0.14% Portfolio value: 530K Avg. open price: $5.42 Current price: $1.86 P/L: -65.68% Bought +52.16% shares Q1 2022	share	0.14%	530K	$5.42	$1.86	-65.68%	Bought +52.16% shares Q1 2022
Biotechnology NextCure, Inc. Portfolio share: 0.14% Portfolio value: 516K Avg. open price: $13.9 Current price: $1.4 P/L: -89.92% Bought +2.29% shares Q4 2021	share	0.14%	516K	$13.9	$1.4	-89.92%	Bought +2.29% shares Q4 2021
Medical Care Facilities COMPASS Pathways plc Portfolio share: 0.14% Portfolio value: 508K Avg. open price: N/A Current price: $10.79 P/L: N/A Sold -36.72% shares Q3 2022	share	0.14%	508K	N/A	$10.79	N/A	Sold -36.72% shares Q3 2022
Biotechnology ProQR Therapeutics N.V. Portfolio share: 0.13% Portfolio value: 483K Avg. open price: $6.52 Current price: $1.41 P/L: -78.36% N/A Q3 2022	share	0.13%	483K	$6.52	$1.41	-78.36%	N/A Q3 2022
Biotechnology Theseus Pharmaceuticals, Inc. Portfolio share: 0.13% Portfolio value: 475K Avg. open price: $11.53 Current price: $6.03 P/L: -47.70% Bought +2.22% shares Q2 2022	share	0.13%	475K	$11.53	$6.03	-47.70%	Bought +2.22% shares Q2 2022
Biotechnology Sutro Biopharma, Inc. Portfolio share: 0.12% Portfolio value: 451K Avg. open price: $11.66 Current price: $7.39 P/L: -36.63% Sold -4.13% shares Q3 2022	share	0.12%	451K	$11.66	$7.39	-36.63%	Sold -4.13% shares Q3 2022
Biotechnology Ikena Oncology, Inc. Portfolio share: 0.12% Portfolio value: 435K Avg. open price: N/A Current price: $2.23 P/L: N/A N/A Q3 2022	share	0.12%	435K	N/A	$2.23	N/A	N/A Q3 2022
Biotechnology Otonomy, Inc. Portfolio share: 0.12% Portfolio value: 434K Avg. open price: $2.66 Current price: $0.13 P/L: -95.07% Sold -1.82% shares Q2 2022	share	0.12%	434K	$2.66	$0.13	-95.07%	Sold -1.82% shares Q2 2022
Biotechnology Compass Therapeutics, Inc. Portfolio share: 0.12% Portfolio value: 429K Avg. open price: $1.37 Current price: $4.53 P/L: +230.66% Sold -5.05% shares Q3 2022	share	0.12%	429K	$1.37	$4.53	+230.66%	Sold -5.05% shares Q3 2022
Medical Devices Venus Concept Inc. Portfolio share: 0.11% Portfolio value: 426K Avg. open price: N/A Current price: $0.28 P/L: N/A Sold -0.77% shares Q1 2022	share	0.11%	426K	N/A	$0.28	N/A	Sold -0.77% shares Q1 2022
Medical Instruments & Supplies Masimo Corporation Portfolio share: 0.11% Portfolio value: 423K Avg. open price: $92.22 Current price: $142.55 P/L: +54.58% Sold -40.00% shares Q3 2018	share	0.11%	423K	$92.22	$142.55	+54.58%	Sold -40.00% shares Q3 2018
Biotechnology Adaptimmune Therapeutics plc Portfolio share: 0.10% Portfolio value: 377K Avg. open price: $5.16 Current price: $1.95 P/L: -62.18% Bought +157.63% shares Q1 2022	share	0.10%	377K	$5.16	$1.95	-62.18%	Bought +157.63% shares Q1 2022
Medical Devices Inogen, Inc. Portfolio share: 0.10% Portfolio value: 364K Avg. open price: $95.37 Current price: $21.4 P/L: -77.56% Sold -34.78% shares Q2 2020	share	0.10%	364K	$95.37	$21.4	-77.56%	Sold -34.78% shares Q2 2020
Biotechnology MacroGenics, Inc. Portfolio share: 0.09% Portfolio value: 346K Avg. open price: $19.4 Current price: $6.38 P/L: -67.11% Sold -47.92% shares Q3 2022	share	0.09%	346K	$19.4	$6.38	-67.11%	Sold -47.92% shares Q3 2022
Biotechnology Biomea Fusion, Inc. Portfolio share: 0.09% Portfolio value: 339K Avg. open price: $7.51 Current price: $6.77 P/L: -9.85% Sold -74.71% shares Q3 2022	share	0.09%	339K	$7.51	$6.77	-9.85%	Sold -74.71% shares Q3 2022
Biotechnology Spero Therapeutics, Inc. Portfolio share: 0.07% Portfolio value: 250K Avg. open price: $11.75 Current price: $1.89 P/L: -83.91% N/A Q3 2022	share	0.07%	250K	$11.75	$1.89	-83.91%	N/A Q3 2022
Biotechnology Lineage Cell Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 158K Avg. open price: $2.5 Current price: $1.41 P/L: -43.60% Bought +75.00% shares Q1 2022	share	0.04%	158K	$2.5	$1.41	-43.60%	Bought +75.00% shares Q1 2022
Biotechnology Reunion Neuroscience Inc. Portfolio share: 0.04% Portfolio value: 138K Avg. open price: N/A Current price: $1.31 P/L: N/A N/A Q3 2022	share	0.04%	138K	N/A	$1.31	N/A	N/A Q3 2022
Biotechnology Compugen Ltd. Portfolio share: 0.04% Portfolio value: 135K Avg. open price: $7.7 Current price: $1.1 P/L: -85.72% Bought +57.60% shares Q2 2022	share	0.04%	135K	$7.7	$1.1	-85.72%	Bought +57.60% shares Q2 2022
Biotechnology PhaseBio Pharmaceuticals, Inc. Portfolio share: 0.02% Portfolio value: 57K Avg. open price: $7.48 Current price: $0.07 P/L: -99.06% Sold -14.99% shares Q3 2022	share	0.02%	57K	$7.48	$0.07	-99.06%	Sold -14.99% shares Q3 2022
Biotechnology LAVA Therapeutics N.V. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $10.88 Current price: $6.17 P/L: -43.29% Sold -100.00% shares Q3 2022	share	0.00%	0	$10.88	$6.17	-43.29%	Sold -100.00% shares Q3 2022
Biotechnology Wave Life Sciences Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $41.5 Current price: $4.25 P/L: -89.76% Sold -100.00% shares Q3 2022	share	0.00%	0	$41.5	$4.25	-89.76%	Sold -100.00% shares Q3 2022
Biotechnology Rigel Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.28 Current price: $0.95 P/L: -71.07% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.28	$0.95	-71.07%	Sold -100.00% shares Q3 2022
Medical Care Facilities Field Trip Health Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.59 Current price: $0.84 P/L: -67.49% Sold -100.00% shares Q3 2022	share	0.00%	0	$2.59	$0.84	-67.49%	Sold -100.00% shares Q3 2022
RADIUS HEALTH INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Radius Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.14 Current price: $10.08 P/L: -41.20% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.14	$10.08	-41.20%	Sold -100.00% shares Q3 2022
Biotechnology Turning Point Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $76.97 Current price: $76.01 P/L: -1.25% Sold -100.00% shares Q3 2022	share	0.00%	0	$76.97	$76.01	-1.25%	Sold -100.00% shares Q3 2022
Biotechnology Connect Biopharma Holdings Limited Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.71 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.71	N/A	Sold -100.00% shares Q3 2022
Biotechnology ASLAN Pharmaceuticals Limited Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $1.75 Current price: $0.53 P/L: -69.60% Sold -100.00% shares Q3 2022	share	0.00%	0	$1.75	$0.53	-69.60%	Sold -100.00% shares Q3 2022
Biotechnology Annexon, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $9.54 Current price: $5.74 P/L: -39.81% Sold -100.00% shares Q3 2022	share	0.00%	0	$9.54	$5.74	-39.81%	Sold -100.00% shares Q3 2022
Medical Devices Natus Medical Incorporated Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $25.34 Current price: $32.96 P/L: +30.05% Sold -100.00% shares Q3 2022	share	0.00%	0	$25.34	$32.96	+30.05%	Sold -100.00% shares Q3 2022
Biotechnology Madrigal Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $86.22 Current price: $72.87 P/L: -15.48% Sold -100.00% shares Q3 2022	share	0.00%	0	$86.22	$72.87	-15.48%	Sold -100.00% shares Q3 2022

Showing TOP 99 DAFNA CAPITAL MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of DAFNA CAPITAL MANAGEMENT LLC?

The biggest position of the DAFNA CAPITAL MANAGEMENT LLC is SPDR S&P Biotech ETF (XBI) with 12.07% portfolio share worth of 44.9M US dollars.

Top 5 DAFNA CAPITAL MANAGEMENT's holdings represent 31.57% of the portfolio:

SPDR S&P Biotech ETF (XBI) – 12.07%
Stereotaxis, Inc. (STXS) – 6.62%
Blueprint Medicines Corporation (BPMC) – 4.63%
Biohaven Ltd. (BHVN) – 4.48%
Ascendis Pharma A/S (ASND) – 3.77%

Who is the portfolio manager of DAFNA CAPITAL MANAGEMENT LLC?

The portfolio manager of the DAFNA CAPITAL MANAGEMENT LLC is .

What is the total asset value of the DAFNA CAPITAL MANAGEMENT LLC portfolio?

DAFNA CAPITAL MANAGEMENT LLC total asset value (portfolio value) is 371.81M US dollars.

Who is ?

is the portfolio manager of the DAFNA CAPITAL MANAGEMENT LLC.

What is (DAFNA CAPITAL MANAGEMENT LLC) fund performance?

DAFNA CAPITAL MANAGEMENT's quarterly performance is +9.33%, annualy -39.67%. In the past 3 years, the value of 's portfolio has increased by +7%. In the past 5 years, the value of the portfolio has increased by +56%.

What is the DAFNA CAPITAL MANAGEMENT LLC CIK?

DAFNA CAPITAL MANAGEMENT's Central Index Key is 0001389933 .

DAFNA CAPITAL MANAGEMENT LLC Holdings

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

DAFNA CAPITAL MANAGEMENT LLC 1 year portfolio value change:

DAFNA CAPITAL MANAGEMENT LLC 3 years portfolio value change:

DAFNA CAPITAL MANAGEMENT LLC 5 years portfolio value change: